Literature DB >> 12091263

Sexual dysfunction in patients taking conventional antipsychotic medication.

S M Smith1, V O'Keane, R Murray.   

Abstract

BACKGROUND: Antipsychotic drugs are associated with sexual dysfunction but the mechanisms are poorly understood. AIMS: To ascertain the frequency of sexual dysfunction in patients taking conventional antipsychotics and to determine the possible underlying mechanisms.
METHOD: Sexual dysfunction was assessed in 101 patients receiving conventional antipsychotic medication, 57 normal controls and 55 controls attending a sexual dysfunction clinic.
RESULTS: Sexual dysfunction occurred in 45% of patients taking antipsychotic medication, 17% of normal controls and 61% of controls attending a sexual dysfunction clinic. Sexual dysfunction was associated with autonomic side-effects in normoprolactinaemic males, but the presence of hyperprolactinaemia overrode other causes of sexual dysfunction. For women, hyperprolactinaemia was the main cause of sexual dysfunction.
CONCLUSIONS: Conventional anti-psychotic medications cause significant levels of sexual dysfunction. Clinicians should routinely enquire about sexual symptoms prior to the prescription of antipsychotics and on follow-up.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091263     DOI: 10.1192/bjp.181.1.49

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  39 in total

1.  Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis.

Authors:  Louise Howard; Roger Webb; Kathryn Abel
Journal:  BMJ       Date:  2004-10-23

Review 2.  Biochemical diagnosis in prolactinomas: some caveats.

Authors:  Stephan Petersenn
Journal:  Pituitary       Date:  2020-02       Impact factor: 4.107

3.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

Review 4.  Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Authors:  Wolfgang Aichhorn; Alexandra B Whitworth; Elisabeth M Weiss; Josef Marksteiner
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.

Authors:  Michael J Crawford; Lavanya Thana; Rachel Evans; Alexandra Carne; Lesley O'Connell; Amy Claringbold; Arunan Saravanamuthu; Rebecca Case; Jasna Munjiza; Sandra Jayacodi; Joseph G Reilly; Elizabeth Hughes; Zoe Hoare; Barbara Barrett; Verity C Leeson; Carol Paton; Patrick Keown; Sofia Pappa; Charlotte Green; Thomas Re Barnes
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

6.  A Comparative Study of Sexual Dysfunction due to Typical and Atypical Antipsychotics in Remitted Bipolar-I Disorder.

Authors:  Anil Kumar M Nagaraj; Haque S Nizamie; Sayeed Akhtar; Baxi Neeraj P Sinha; Nishant Goyal
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

7.  Antipsychotic-induced sexual dysfunction and its management.

Authors:  Yeon Won Park; Yooseok Kim; Jun Ho Lee
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

8.  Hyperprolactinaemia with amisulpride.

Authors:  Rajnish Raj; Balwant Singh Sidhu
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

9.  A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.

Authors:  Anil Kumar M Nagaraj; Nagesh B Pai; Satheesh Rao
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

10.  A well-being programme in severe mental illness. Baseline findings in a UK cohort.

Authors:  S Smith; D Yeomans; C J P Bushe; C Eriksson; T Harrison; R Holmes; L Mynors-Wallis; H Oatway; G Sullivan
Journal:  Int J Clin Pract       Date:  2007-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.